Literature DB >> 23708912

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.

D M Murphy1, R Bejar, K Stevenson, D Neuberg, Y Shi, C Cubrich, K Richardson, P Eastlake, G Garcia-Manero, H Kantarjian, B L Ebert, G Mike Makrigiorgos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23708912      PMCID： PMC3967719          DOI： 10.1038/leu.2013.160

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.

Authors:  S Misawa; S Horiike; H Kaneko; K Kashima
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

Review 2.  COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.

Authors:  Jin Li; G Mike Makrigiorgos
Journal:  Biochem Soc Trans       Date:  2009-04       Impact factor: 5.407

3.  Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing.

Authors:  Jin Li; Lilin Wang; Harvey Mamon; Matthew H Kulke; Ross Berbeco; G Mike Makrigiorgos
Journal:  Nat Med       Date:  2008-04-13       Impact factor: 53.440

4.  Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion.

Authors:  Martin Jädersten
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 5.  The genetic basis of myelodysplastic syndromes.

Authors:  Rafael Bejar; Benjamin L Ebert
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

6.  NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

Authors:  Carrie Fidler; Fiona Watkins; David T Bowen; Timothy J Littlewood; James S Wainscoat; Jacqueline Boultwood
Journal:  Haematologica       Date:  2004-07       Impact factor: 9.941

7.  Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.

Authors:  L-Y Shih; C-F Huang; P-N Wang; J-H Wu; T-L Lin; P Dunn; M-C Kuo
Journal:  Leukemia       Date:  2004-03       Impact factor: 11.528

Review 8.  PCR-based methods for the enrichment of minority alleles and mutations.

Authors:  Coren A Milbury; Jin Li; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2009-02-06       Impact factor: 8.327

9.  COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations.

Authors:  Coren A Milbury; Jin Li; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2009-10-08       Impact factor: 8.327

10.  Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.

Authors:  Martin Jädersten; Leonie Saft; Andrea Pellagatti; Gudrun Göhring; James S Wainscoat; Jacqueline Boultwood; Anna Porwit; Brigitte Schlegelberger; Eva Hellström-Lindberg
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941
View more
  31 in total

1.  p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q).

Authors:  Leonie Saft; Mohsen Karimi; Mehran Ghaderi; András Matolcsy; Ghulam J Mufti; Austin Kulasekararaj; Gudrun Göhring; Aristoteles Giagounidis; Dominik Selleslag; Petra Muus; Guillermo Sanz; Moshe Mittelman; David Bowen; Anna Porwit; Tommy Fu; Jay Backstrom; Pierre Fenaux; Kyle J MacBeth; Eva Hellström-Lindberg
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

2.  CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.

Authors:  Roni Tamari; Stephen S Chung; Esperanza B Papadopoulos; Ann A Jakubowski; Patrick Hilden; Sean M Devlin; Jenna D Goldberg; Miguel-Angel Perales; Doris M Ponce; Craig S Sauter; Molly A Maloy; Dara Y Herman; Virginia Klimek; James W Young; Richard J O'Reilly; Sergio A Giralt; Hugo Castro-Malaspina
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-14       Impact factor: 5.742

3.  Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome.

Authors:  Julia C Obenauer; François G Kavelaars; Mathijs A Sanders; Remco M Hoogenboezem; Andrica C H de Vries; Paulina M H van Strien; Valerie de Haas; Franco Locatelli; Henrik Hasle; Peter J M Valk; Ivo P Touw; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2016-09-01       Impact factor: 9.941

4.  Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.

Authors:  S Soverini; C De Benedittis; C Papayannidis; K Machova Polakova; C Venturi; D Russo; P Bresciani; A Iurlo; M Mancini; A Vitale; S Chiaretti; R Foà; E Abruzzese; F Sorà; A Kohlmann; T Haferlach; M Baccarani; M Cavo; G Martinelli
Journal:  Leukemia       Date:  2016-02-12       Impact factor: 11.528

5.  DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.

Authors:  Chen Song; Elena Castellanos-Rizaldos; Rafael Bejar; Benjamin L Ebert; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2015-10-02       Impact factor: 8.327

6.  p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.

Authors:  Jingfang Zhang; Guangyao Kong; Adhithi Rajagopalan; Li Lu; Jingming Song; Mohamed Hussaini; Xinmin Zhang; Erik A Ranheim; Yangang Liu; Jinyong Wang; Xin Gao; Yuan-I Chang; Kirby D Johnson; Yun Zhou; David Yang; Bhavana Bhatnagar; David M Lucas; Emery H Bresnick; Xuehua Zhong; Eric Padron; Jing Zhang
Journal:  Blood       Date:  2016-11-04       Impact factor: 22.113

Review 7.  COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.

Authors:  Florence Mauger; Alexandre How-Kit; Jörg Tost
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

8.  Single-tube, highly parallel mutation enrichment in cancer gene panels by use of temperature-tolerant COLD-PCR.

Authors:  Elena Castellanos-Rizaldos; Katherine Richardson; Rui Lin; Grant Wu; Mike G Makrigiorgos
Journal:  Clin Chem       Date:  2014-10-08       Impact factor: 8.327

Review 9.  Genetics of progression from MDS to secondary leukemia.

Authors:  Andrew J Menssen; Matthew J Walter
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

10.  Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

Authors:  Mariana Fitarelli-Kiehl; Fangyan Yu; Ravina Ashtaputre; Ka Wai Leong; Ioannis Ladas; Julianna Supplee; Cloud Paweletz; Devarati Mitra; Jonathan D Schoenfeld; Sareh Parangi; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2018-10-01       Impact factor: 8.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.